Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01265537
What this trial is testing

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

Who this might be right for
Acute Graft RejectionDiabetes
University of British Columbia 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07835581
What this trial is testing

Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 620
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Post-approval studies (Phase 4)Study completedNCT00565474
What this trial is testing

Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant

Who this might be right for
Graft Vasculopathy
Novartis Pharmaceuticals 84
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Large-scale testing (Phase 3)Ended earlyNCT01442337
What this trial is testing

Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 21
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Post-approval studies (Phase 4)Study completedNCT02267512
What this trial is testing

Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

Who this might be right for
De Novo Kidney Transplant Patients
Astellas Pharma Inc 280
Post-approval studies (Phase 4)Study completedNCT00537862
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 200
Post-approval studies (Phase 4)UnknownNCT01744470
What this trial is testing

Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

Who this might be right for
De Novo Transplant Disease
University Hospital, Tours 286
Testing effectiveness (Phase 2)Study completedNCT00483756
What this trial is testing

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer 338
Large-scale testing (Phase 3)Study completedNCT00189202
What this trial is testing

Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

Who this might be right for
End Stage Renal DiseaseKidney Transplantation
University of Michigan 49
Early research (Phase 1)Study completedNCT01279538
What this trial is testing

Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 50
Not applicableNot Yet RecruitingNCT06960824
What this trial is testing

Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence

Who this might be right for
Chronic Renal Disease
Chiesi SAS 165
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Post-approval studies (Phase 4)Study completedNCT00154206
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 15
Post-approval studies (Phase 4)Study completedNCT01706471
What this trial is testing

Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation

Who this might be right for
Planned Kidney Transplantation
Yonsei University 60
Post-approval studies (Phase 4)Study completedNCT00371826
What this trial is testing

SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Who this might be right for
Renal Transplanted Recipients
Novartis Pharmaceuticals 126
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Post-approval studies (Phase 4)Study completedNCT00195468
What this trial is testing

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 280
Next Page